CNS Pharmaceuticals

North America. North America Legal Chronicle. March 11, 2021

CNS Pharmaceuticals’ $11.5 Million Public Offering

By Martina Bellini

Schiff Hardin LLP advised CNS Pharmaceuticals, Inc. on the deal. CNS Pharmaceuticals, Inc. announced its public offering of 5,750,000 shares of common stock and 2,875,000 warrants to...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Benedict Realty Group’s $46.5 Million Acquisition of Multifamily Portfolio in Queens

Piedmont Lithium’s Merger with Sayona Mining

Zenflow’s $24 Million Series C Financing Round

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

Celcoin’s Acquisition of CobranSaaS

Alchemy US Holdco 1’s Refinancing of Term Loan and ABL Credit Agreements

Ardian’s Acquisition of a Majority Interest in Vista Vision

Pivotal’s Acquisition of Security Plus Limited

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Firstsource Solutions UK Limited’s £42 Million Acquisition Of Ascensos Limited

Cathay Pacific Airways Ltd’s HK$6.732 Billion Convertible Bonds Issuance

China Water Affairs Group Limited’s HK$361 Million Exchangeable Bonds Offering

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

CNS Pharmaceuticals’ $11.5 Million Public Offering

Standard 1 Year Membership Required